Bayer Avelox
Moxifloxacin was approved with a bolded warning about QT interval prolongation. A story summary in "The Pink Sheet" (Dec. 20, p. 1) misidentified the cautionary statement as a black box warning
Moxifloxacin was approved with a bolded warning about QT interval prolongation. A story summary in "The Pink Sheet" (Dec. 20, p. 1) misidentified the cautionary statement as a black box warning